rcept_no,reprt_code,bsns_year,corp_code,sj_div,sj_nm,account_id,account_nm,account_detail,thstrm_nm,thstrm_amount,frmtrm_nm,frmtrm_amount,bfefrmtrm_nm,bfefrmtrm_amount,ord,currency,thstrm_add_amount,source,requested_fs_div,requested_reprt_code,requested_sj_div,peer_stock_code,peer_corp_name
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 20,1982768917805,Term 19,2163074840988,Term 18,1691202854302,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 20,434105464098,Term 19,647104059171,Term 18,396643798594,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 20,58536528000,Term 19,72263450599,Term 18,16900000000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 20,637791666835,Term 19,645650629829,Term 18,581868123660,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 20,585564696288,Term 19,611044864691,Term 18,556088266669,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 20,52226970547,Term 19,34605765138,Term 18,25779856991,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 20,808965987719,Term 19,746323199447,Term 18,614747846838,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 20,373764592,Term 19,1089659831,Term 18,23590117,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 20,42995506561,Term 19,50643842111,Term 18,81019495093,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 20,4818646865905,Term 19,4330594821983,Term 18,3584671429863,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 20,20000000,Term 19,24000000,Term 18,24000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 20,50353958215,Term 19,80180225757,Term 18,78324507595,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 20,59998748118,Term 19,56559112536,Term 18,52392994727,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 20,38749519773,Term 19,37441744173,Term 18,21123266919,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 20,2329834013415,Term 19,2036044655189,Term 18,1813288570135,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 20,219793014823,Term 19,273157209374,Term 18,0,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 20,24759532927,Term 19,42239252222,Term 18,45184246888,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 20,2063442867186,Term 19,1787313564367,Term 18,1544973448428,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 20,9768003713,Term 19,9467262843,Term 18,10397354014,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 20,21927207735,Term 19,8167795522,Term 18,18963041157,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 20,6801415783710,Term 19,6493669662971,Term 18,5275874284165,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 20,1479723875311,Term 19,1771203779670,Term 18,1358883491897,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 20,779910998828,Term 19,1034527055707,Term 18,848560014566,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 20,251186196633,Term 19,290674359917,Term 18,215581212474,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 20,338733244659,Term 19,352651064454,Term 18,258640013188,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 20,186412985536,Term 19,287644127872,Term 18,210810384650,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 20,3578572000,Term 19,3566080000,Term 18,13566080000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 20,,Term 19,99991423464,Term 18,149962324254,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 20,180411503449,Term 19,200760674566,Term 18,192627804993,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,환불부채,-,Term 20,15621411384,Term 19,17506962997,Term 18,16700325094,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 20,349310770860,Term 19,351652442060,Term 18,199699051620,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 20,154469190790,Term 19,166756644340,Term 18,101296295624,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 20,472496209534,Term 19,485378218165,Term 18,322970664268,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 20,57308752150,Term 19,47598060022,Term 18,114364255911,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 20,22801783421,Term 19,3566080000,Term 18,7132160000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,-Standard account code not used-,장기기타채무,-,Term 20,,Term 19,8646253131,Term 18,,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 20,29999854078,Term 19,29999727873,Term 18,99907049975,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 20,4507114651,Term 19,5385999018,Term 18,7325045936,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 20,48752783196,Term 19,67532645988,Term 18,34256838606,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 20,131795665327,Term 19,95549343156,Term 18,119995728100,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 20,157269496925,Term 19,227136200242,Term 18,23936993871,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 20,77369511936,Term 19,47561968757,Term 18,30416847780,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 20,1952220084845,Term 19,2256581997835,Term 18,1681854156165,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 20,4755979504489,Term 19,4146733740179,Term 18,3512066419513,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 20,4805404131407,Term 19,4174881534589,Term 18,3563364542417,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 20,-124122981721,Term 19,-96636000943,Term 18,-121624601514,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 20,-111216852980,Term 19,-117427001250,Term 18,-115588729173,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 20,93216194376,Term 19,90353924957,Term 18,81953708487,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 20,4849195698865,Term 19,4237087665136,Term 18,3594020128000,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 20,6801415783710,Term 19,6493669662971,Term 18,5275874284165,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 20,7844506057131,Term 19,7685424230297,Term 18,6747536801608,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 20,2962930553558,Term 19,2917246274571,Term 18,2696414092278,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 20,4881575503573,Term 19,4768177955726,Term 18,4051122709330,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 20,3660710772262,Term 19,3591766708822,Term 18,3011872573693,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 20,1220864731311,Term 19,1176411246904,Term 18,1039250135637,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 20,15434807035,Term 19,17086461393,Term 18,6486158742,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 20,21616953222,Term 19,17773035035,Term 18,12707249161,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 20,44819578890,Term 19,32917076235,Term 18,24006227891,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 20,145452166970,Term 19,123480423267,Term 18,99710960281,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 20,7024275269,Term 19,6919863873,Term 18,-1319193795,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 20,1121074272313,Term 19,1092081190103,Term 18,956005119033,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 20,307973132289,Term 19,303908097869,Term 18,263726412686,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 20,15472467145,Term 19,10075385067,Term 18,9535552136,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 20,47596,Term 19,46431,Term 18,40740,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 20,47647,Term 19,46481,Term 18,40790,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 20,-10164589640,Term 19,13688171271,Term 18,203490317,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 20,17224431473,Term 19,-13553148202,Term 18,-12578758749,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 20,18549466745,Term 19,-11691231674,Term 18,-11813991316,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 20,-1327783683,Term 19,-1906910378,Term 18,-764767433,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 20,2748411,Term 19,44993850,Term 18,0,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 20,-27389021113,Term 19,27241319473,Term 18,12782249066,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 20,-215096850,Term 19,88177739,Term 18,216104407,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 20,-27173924263,Term 19,27153141734,Term 18,12566144659,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 20,802936550384,Term 19,801861263505,Term 18,692482196664,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 20,787456912990,Term 19,792025521227,Term 18,683409427015,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 20,15479637394,Term 19,9835742278,Term 18,9072769649,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 20,1004842472035,Term 19,1139641474935,Term 18,817116843804,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 20,626194542524,Term 19,651911831070,Term 18,520574156305,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 20,233925508629,Term 19,223940938745,Term 18,135694205295,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 20,28295853267,Term 19,27078995902,Term 18,21752965806,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 20,50474494996,Term 19,46396918588,Term 18,43993371189,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 20,595482883,Term 19,231152265,Term 18,-182012119,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 20,120354050,Term 19,498555701,Term 18,-958326063,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 20,12507879942,Term 19,13870018114,Term 18,10135518970,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 20,2555055538,Term 19,2210056526,Term 18,1269641235,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 20,,Term 19,,Term 18,910411462,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 20,,Term 19,48496900,Term 18,882420015,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 20,2431280464,Term 19,,Term 18,,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfFinancialAssets,당기손익-공정가치 측정 금융자산 처분손실,-,Term 20,22428828,Term 19,29066269,Term 18,,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfFinancialAssets,당기손익-공정가치 측정 금융자산 처분이익,-,Term 20,,Term 19,1370300650,Term 18,,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 20,-3205933336,Term 19,-1405338340,Term 18,-527375520,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 20,7796049548,Term 19,7471500310,Term 18,10130107174,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 20,122712135,Term 19,12145224,Term 18,,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 20,1179758364,Term 19,1709806609,Term 18,435956321,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 20,12559557,Term 19,40106066,Term 18,,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 20,958695011,Term 19,8172548599,Term 18,10847999340,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 20,2723414919,Term 19,2076269660,Term 18,931553838,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 20,56925461,Term 19,41517092546,Term 18,28981153390,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 20,307973132289,Term 19,303908097869,Term 18,263726412686,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 20,4984491548,Term 19,8700706278,Term 18,3836339122,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 20,933000000,Term 19,28256000,Term 18,19281900,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 20,1444637923,Term 19,1771727446,Term 18,992074598,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 20,3539815333,Term 19,6156226718,Term 18,2007434469,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 20,3740590000,Term 19,112545282,Term 18,,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 20,466778724,Term 19,226562693,Term 18,59960552,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 20,-217521224,Term 19,-58412806,Term 18,,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 20,7024275269,Term 19,6919863873,Term 18,-1319193795,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,자산수증이익,-,Term 20,,Term 19,,Term 18,-33126944,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 20,,Term 19,549994737,Term 18,,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 20,-97771906662,Term 19,15693436344,Term 18,-154376186486,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 20,22475967366,Term 19,-22581565164,Term 18,3678536884,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 20,4352829222,Term 19,17762470159,Term 18,840888309,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 20,-67826527783,Term 19,-31006365565,Term 18,-43471253195,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 20,12117381977,Term 19,-6138979641,Term 18,-57652675241,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기타유동금융자산,-,Term 20,,Term 19,734507866,Term 18,,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 20,-7901977197,Term 19,,Term 18,-3945464731,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 20,-30067851787,Term 19,2410984772,Term 18,-42740446487,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 20,22469667835,Term 19,70917430472,Term 18,21884680463,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 20,-549255134,Term 19,-874540704,Term 18,-7970704222,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 20,-12986505720,Term 19,30299904461,Term 18,30050165944,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 20,-8576068399,Term 19,21482822264,Term 18,5310730780,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 20,-554689404,Term 19,-2382570699,Term 18,380920581,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 20,7374041609,Term 19,4565340718,Term 18,4438869046,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 20,825666713,Term 19,-461390214,Term 18,961181937,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 20,-54936455806,Term 19,-66366829778,Term 18,-64309539715,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 20,30759953064,Term 19,6462898833,Term 18,7045661253,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 20,4959977013,Term 19,7587742626,Term 18,4612293973,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 20,4227270000,Term 19,2901037478,Term 18,2483354511,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 20,8700381507,Term 19,10180156104,Term 18,11628566111,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 20,337168169357,Term 19,316445508713,Term 18,236826914735,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 20,-745883641217,Term 19,-461380844546,Term 18,-430292259476,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 20,76200000999,Term 19,15055168850,Term 18,7043340694,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 20,894557167,Term 19,37975273738,Term 18,2418554769,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 20,4000000,Term 19,,Term 18,492738779,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 20,9748658623,Term 19,64308271893,Term 18,19766011640,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 20,1173000000,Term 19,558934331,Term 18,,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 20,6797791333,Term 19,12659860186,Term 18,3295995994,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 20,4760000000,Term 19,340000000,Term 18,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 20,9906597662,Term 19,463027231,Term 18,95000000,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금흐름 유입,-,Term 20,,Term 19,2666361770,Term 18,,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 설립,-,Term 20,,Term 19,50000010000,Term 18,7846162460,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 20,62500000000,Term 19,70341850599,Term 18,5000000000,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 20,178968162,Term 19,254010544,Term 18,695071784,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 20,3927857300,Term 19,65426828092,Term 18,11320272647,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_PurchaseOfOtherNonCurrentFinancialAssets,기타비유동금융자산의 취득,-,Term 20,,Term 19,,Term 18,200000000,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 20,505743484068,Term 19,326089104184,Term 18,356284941186,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 20,13128703763,Term 19,8973731170,Term 18,7842597936,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,사업결합으로 인한 현금유출,-,Term 20,269889233708,Term 19,174322227956,Term 18,89907180259,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 20,-465737759835,Term 19,-429403943010,Term 18,-378036987192,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 20,96944735692,Term 19,271711203706,Term 18,323462505217,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 20,22736389421,Term 19,,Term 18,2356000000,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_ProceedsFromBonds,사채의 증가,-,Term 20,,Term 19,29999620000,Term 18,,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 20,194202086120,Term 19,323425777729,Term 18,237236106490,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 20,3567121000,Term 19,13566080000,Term 18,25064090038,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,사채의 상환,-,Term 20,100000000000,Term 19,150000000000,Term 18,262437762000,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,전환사채의 상환,-,Term 20,,Term 19,,Term 18,-5377972602,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,리스부채의 지급,-,Term 20,91236233038,Term 19,80342388920,Term 18,139468422,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업투자의 취득,-,Term 20,,Term 19,-5190000000,Term 18,-11875640983,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,배당금의 지급,-,Term 20,196413444790,Term 19,158590520067,Term 18,161724451874,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,현금및현금성자산의 증가(감소),-,Term 20,-206778929017,Term 19,248856687379,Term 18,8787597136,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,기초의 현금및현금성자산,-,Term 20,647104059171,Term 19,396643798594,Term 18,386194252722,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,현금및현금성자산의 환율변동효과,-,Term 20,-300879719,Term 19,-695843313,Term 18,224665532,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 20,-5918786337,Term 19,2299416511,Term 18,1437283204,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 20,434105464098,Term 19,647104059171,Term 18,396643798594,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,4174881534589,Term 19,3563364542417,Term 18,3044143111385,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-96636000943,Term 19,-121624601514,Term 18,-132783664248,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 20,4237087665136,Term 19,3594020128000,Term 18,3081783034671,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 20,90353924957,Term 19,81953708487,Term 18,85547807496,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,4146733740179,Term 19,3512066419513,Term 18,2996235227175,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,-117427001250,Term 19,-115588729173,Term 18,-101039427745,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,,Term 19,,Term 18,-1394297397,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,,Term 19,,Term 18,-725417902,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,연결재무제표 [member],Term 20,,Term 19,,Term 18,-2119715299,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInAccountingPolicies,회계정책변경의 효과,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,,Term 19,,Term 18,-2119715299,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,797628672879,Term 19,778097707167,Term 18,682743154211,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 20,15472467145,Term 19,10075385067,Term 18,9535552136,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 20,813101140024,Term 19,788173092234,Term 18,692278706347,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,18312461353,Term 19,-11105780361,Term 18,-11201797236,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,18312461353,Term 19,-11105780361,Term 18,-11201797236,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 20,18549466745,Term 19,-11691231674,Term 18,-11813991316,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 20,237005392,Term 19,-585451313,Term 18,-612194080,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|비지배지분 [member],Term 20,,Term 19,,Term 18,-33673837,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-731093596,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-731093596,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 20,-1327783683,Term 19,-1906910378,Term 18,-764767433,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,2748411,Term 19,44993850,Term 18,,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,-999988875,Term 19,,Term 18,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,999988875,Term 19,,Term 18,,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-215096850,Term 19,88177739,Term 18,216104407,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 20,-27173924263,Term 19,27153141734,Term 18,12566144659,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 20,-229835143,Term 19,345808524,Term 18,183085430,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,-26944089120,Term 19,26807333210,Term 18,12383059229,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-26944089120,Term 19,26807333210,Term 18,12383059229,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,184421296950,Term 19,155098219951,Term 18,150909217950,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 20,196421296950,Term 19,158378373762,Term 18,161734054457,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 20,12000000000,Term 19,3280153811,Term 18,10824836507,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,184421296950,Term 19,155098219951,Term 18,150909217950,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 20,5592780295,Term 19,-415352607,Term 18,-16391333579,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,6210148270,Term 19,-2259980610,Term 18,-14549301428,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,6210148270,Term 19,-1838272077,Term 18,-14549301428,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 20,-617367975,Term 19,1844628003,Term 18,-1842032151,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,,Term 19,-421708533,Term 18,-16410596,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,,Term 19,,Term 18,16410596,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 20,93216194376,Term 19,90353924957,Term 18,81953708487,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 20,4755979504489,Term 19,4146733740179,Term 18,3512066419513,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 20,-111216852980,Term 19,-117427001250,Term 18,-115588729173,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 20,97325737783,Term 19,97325737783,Term 18,97325737783,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 20,88589470000,Term 19,88589470000,Term 18,88589470000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 20,4849195698865,Term 19,4237087665136,Term 18,3594020128000,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 20,-124122981721,Term 19,-96636000943,Term 18,-121624601514,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20210311001010,11011,2020,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 20,4805404131407,Term 19,4174881534589,Term 18,3563364542417,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 21,2472884295774,Term 20,1982768917805,Term 19,2163074840988,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 21,734520611733,Term 20,434105464098,Term 19,647104059171,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 21,95352448800,Term 20,58536528000,Term 19,72263450599,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 21,592964794438,Term 20,637791666835,Term 19,645650629829,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 21,554857050527,Term 20,585564696288,Term 19,611044864691,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 21,38107743911,Term 20,52226970547,Term 19,34605765138,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 21,1000655942465,Term 20,808965987719,Term 19,746323199447,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 21,824675343,Term 20,373764592,Term 19,1089659831,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 21,48565822995,Term 20,42995506561,Term 19,50643842111,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 21,5082355121943,Term 20,4818646865905,Term 19,4330594821983,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 21,20000000,Term 20,20000000,Term 19,24000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 21,49092915577,Term 20,50353958215,Term 19,80180225757,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 21,59167859842,Term 20,59998748118,Term 19,56559112536,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 21,38593929168,Term 20,38749519773,Term 19,37441744173,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 21,2449112181346,Term 20,2329834013415,Term 19,2036044655189,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 21,204288160278,Term 20,219793014823,Term 19,273157209374,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 21,30129279961,Term 20,24759532927,Term 19,42239252222,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 21,2168719935017,Term 20,2063442867186,Term 19,1787313564367,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 21,28409958922,Term 20,9768003713,Term 19,9467262843,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 21,54820901832,Term 20,21927207735,Term 19,8167795522,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 21,7555239417717,Term 20,6801415783710,Term 19,6493669662971,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 21,1525844759254,Term 20,1479723875311,Term 19,1771203779670,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 21,862367973560,Term 20,779910998828,Term 19,1034527055707,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 21,270571519551,Term 20,251186196633,Term 19,290674359917,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 21,299660142515,Term 20,338733244659,Term 19,352651064454,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 21,256676145850,Term 20,186412985536,Term 19,287644127872,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 21,5460181804,Term 20,3578572000,Term 19,3566080000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 21,29999983840,Term 20,0,Term 19,99991423464,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 21,188801478806,Term 20,180411503449,Term 19,200760674566,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,유동반품충당부채,-,Term 21,12875692276,Term 20,15621411384,Term 19,17506962997,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 21,330577242027,Term 20,349310770860,Term 19,351652442060,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 21,131222372585,Term 20,154469190790,Term 19,166756644340,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 21,531561847107,Term 20,472496209534,Term 19,485378218165,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 21,21237095226,Term 20,57308752150,Term 19,47598060022,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 21,17341601617,Term 20,22801783421,Term 19,3566080000,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,-Standard account code not used-,장기기타채무,-,Term 21,0,Term 20,0,Term 19,8646253131,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 21,0,Term 20,29999854078,Term 19,29999727873,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 21,3895493609,Term 20,4507114651,Term 19,5385999018,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 21,51421810319,Term 20,48752783196,Term 19,67532645988,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 21,121735464959,Term 20,131795665327,Term 19,95549343156,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 21,263149536421,Term 20,157269496925,Term 19,227136200242,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 21,74017940182,Term 20,77369511936,Term 19,47561968757,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 21,2057406606361,Term 20,1952220084845,Term 19,2256581997835,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 21,5388010154330,Term 20,4755979504489,Term 19,4146733740179,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 21,5484022033744,Term 20,4805404131407,Term 19,4174881534589,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 21,-64495577286,Term 20,-124122981721,Term 19,-96636000943,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 21,-217431509911,Term 20,-111216852980,Term 19,-117427001250,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 21,109822657026,Term 20,93216194376,Term 19,90353924957,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 21,5497832811356,Term 20,4849195698865,Term 19,4237087665136,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 21,7555239417717,Term 20,6801415783710,Term 19,6493669662971,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 21,8091511297961,Term 20,7844506057131,Term 19,7685424230297,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 21,3039883555040,Term 20,2962930553558,Term 19,2917246274571,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 21,5051627742921,Term 20,4881575503573,Term 19,4768177955726,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 21,3761997319316,Term 20,3660710772262,Term 19,3591766708822,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 21,1289630423605,Term 20,1220864731311,Term 19,1176411246904,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 21,9572005157,Term 20,15434807035,Term 19,17086461393,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 21,22886303361,Term 20,21616953222,Term 19,17773035035,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 21,54382716863,Term 20,44819578890,Term 19,32917076235,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 21,148406751184,Term 20,145452166970,Term 19,123480423267,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 21,5072767505,Term 20,7024275269,Term 19,6919863873,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 21,1187364858585,Term 20,1121074272313,Term 19,1092081190103,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 21,326237006705,Term 20,307973132289,Term 19,303908097869,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 21,844523495741,Term 20,797628672879,Term 19,778097707167,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 21,16604356139,Term 20,15472467145,Term 19,10075385067,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 21,50395,Term 20,47596,Term 19,46431,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 21,50445,Term 20,47647,Term 19,46481,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 21,79793999467,Term 20,-10164589640,Term 19,13688171271,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 21,18624875033,Term 20,17224431473,Term 19,-13553148202,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 21,18774536960,Term 20,18549466745,Term 19,-11691231674,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 21,0,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 21,61169124434,Term 20,-27389021113,Term 19,27241319473,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 21,234458815,Term 20,-215096850,Term 19,88177739,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 21,60934665619,Term 20,-27173924263,Term 19,27153141734,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 21,940921851347,Term 20,802936550384,Term 19,801861263505,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 21,922666603722,Term 20,787456912990,Term 19,792025521227,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 21,18255247625,Term 20,15479637394,Term 19,9835742278,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 21,984481666368,Term 20,1004842472035,Term 19,1139641474935,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 21,655594377448,Term 20,626194542524,Term 19,651911831070,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 21,240917419595,Term 20,233925508629,Term 19,223940938745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 21,34129748348,Term 20,28295853267,Term 19,27078995902,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 21,50413856656,Term 20,50474494996,Term 19,46396918588,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 21,12537198896,Term 20,12507879942,Term 19,13870018114,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 21,3729253285,Term 20,595482883,Term 19,231152265,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 21,1233674337,Term 20,2555055538,Term 19,2210056526,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가손실,-,Term 21,4921968498,Term 20,0,Term 19,48496900,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 21,1380318713,Term 20,2431280464,Term 19,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가이익,-,Term 21,-1582418788,Term 20,0,Term 19,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 21,-255798240,Term 20,-3205933336,Term 19,-1405338340,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분손실,-,Term 21,0,Term 20,22428828,Term 19,29066269,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분이익,-,Term 21,0,Term 20,0,Term 19,-1370300650,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 21,4947235977,Term 20,7796049548,Term 19,7471500310,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 21,0,Term 20,122712135,Term 19,12145224,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 21,700100092,Term 20,1179758364,Term 19,1709806609,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 21,87136919,Term 20,12559557,Term 19,40106066,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 21,3695340823,Term 20,958695011,Term 19,8172548599,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 21,0,Term 20,2723414919,Term 19,2076269660,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 21,563290248,Term 20,56925461,Term 19,41517092546,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 21,338700185,Term 20,0,Term 19,0,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 21,326237006705,Term 20,307973132289,Term 19,303908097869,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 21,5680872283,Term 20,4984491548,Term 19,8700706278,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 21,-186600000,Term 20,-933000000,Term 19,-28256000,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 21,-1135147924,Term 20,120354050,Term 19,498555701,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 21,1645379301,Term 20,1444637923,Term 19,1771727446,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentsInAssociates,종속기업/관계기업/공동기업투자처분이익,-,Term 21,6259434084,Term 20,0,Term 19,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 21,7882228803,Term 20,3539815333,Term 19,6156226718,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 21,424275509,Term 20,3740590000,Term 19,112545282,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 21,31400000,Term 20,466778724,Term 19,226562693,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 21,50260469,Term 20,217521224,Term 19,58412806,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 21,5072767505,Term 20,7024275269,Term 19,6919863873,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 21,31288923,Term 20,0,Term 19,549994737,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 21,-232237308874,Term 20,-97771906662,Term 19,15693436344,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 21,48830535465,Term 20,22475967366,Term 19,-22581565164,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 21,7439955809,Term 20,4352829222,Term 19,17762470159,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 21,-147805686623,Term 20,-67826527783,Term 19,-31006365565,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 21,3246409858,Term 20,12117381977,Term 19,-6138979641,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동비금융자산,-,Term 21,0,Term 20,0,Term 19,734507866,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동자산,-,Term 21,-5825558786,Term 20,-7901977197,Term 19,0,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 21,5129900386,Term 20,-30067851787,Term 19,2410984772,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 21,-31106874116,Term 20,22469667835,Term 19,70917430472,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 21,-3017943114,Term 20,-549255134,Term 19,-874540704,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 21,-12476452211,Term 20,-12986505720,Term 19,30299904461,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 21,-33517901510,Term 20,-8576068399,Term 19,21482822264,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 21,-1293303890,Term 20,-554689404,Term 19,-2382570699,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 21,4891083551,Term 20,7374041609,Term 19,4565340718,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 21,561746152,Term 20,825666713,Term 19,-461390214,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 21,-55921334529,Term 20,-54936455806,Term 19,-66366829778,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 21,-1589718214,Term 20,30759953064,Term 19,6462898833,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 21,4850875119,Term 20,4959977013,Term 19,7587742626,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 21,6384911352,Term 20,4227270000,Term 19,2901037478,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 21,7982482336,Term 20,8700381507,Term 19,10180156104,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 21,303256558221,Term 20,337168169357,Term 19,316445508713,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 21,-465122432772,Term 20,-745883641217,Term 19,-461380844546,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 21,42000000000,Term 20,76200000999,Term 19,15055168850,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 21,7150005783,Term 20,894557167,Term 19,37975273738,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 21,0,Term 20,4000000,Term 19,0,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 21,2286461472,Term 20,9748658623,Term 19,64308271893,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 21,0,Term 20,1173000000,Term 19,558934331,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInAssociates,관계기업에 대한 투자자산의 처분,-,Term 21,16943803,Term 20,0,Term 19,,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 21,17970989609,Term 20,6797791333,Term 19,12659860186,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 21,2360000000,Term 20,4760000000,Term 19,340000000,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 21,270342552,Term 20,9906597662,Term 19,463027231,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 21,253700000,Term 20,0,Term 19,0,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,종속기업 처분으로 인한 순현금유입액,-,Term 21,7364927342,Term 20,0,Term 19,2666361770,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 설립,-,Term 21,0,Term 20,0,Term 19,50000010000,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 21,76229000000,Term 20,62500000000,Term 19,70341850599,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 21,696100059,Term 20,178968162,Term 19,254010544,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 21,4563158125,Term 20,3927857300,Term 19,65426828092,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 21,321874697496,Term 20,505743484068,Term 19,326089104184,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 21,12528920,Term 20,0,Term 19,0,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 21,10312236474,Term 20,13128703763,Term 19,8973731170,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금 유출,-,Term 21,131108082259,Term 20,269889233708,Term 19,174322227956,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 21,-238400403869,Term 20,-465737759835,Term 19,-429403943010,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 21,211508361822,Term 20,96944735692,Term 19,271711203706,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 21,0,Term 20,22736389421,Term 19,0,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 유상증자,-,Term 21,120000000,Term 20,0,Term 19,0,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,사채의 발행,-,Term 21,0,Term 20,0,Term 19,29999620000,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 21,160451258420,Term 20,194202086120,Term 19,323425777729,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 21,3578572000,Term 20,3567121000,Term 19,13566080000,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,유동성사채의 상환,-,Term 21,0,Term 20,100000000000,Term 19,150000000000,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 21,85093142807,Term 20,91236233038,Term 19,80342388920,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업투자의 취득,-,Term 21,14770273001,Term 20,0,Term 19,5190000000,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금지급,-,Term 21,186135519463,Term 20,196413444790,Term 19,158590520067,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,환율변동효과 반영전 현금및현금성자산의 순증가(감소),-,Term 21,280958829727,Term 20,-206778929017,Term 19,248856687379,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 21,434105464098,Term 20,647104059171,Term 19,396643798594,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 21,325780165,Term 20,-300879719,Term 19,-695843313,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 21,19130537743,Term 20,-5918786337,Term 19,2299416511,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 21,734520611733,Term 20,434105464098,Term 19,647104059171,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,4805404131407,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-124122981721,Term 20,-96636000943,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 21,4849195698865,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 21,93216194376,Term 20,90353924957,Term 19,81953708487,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,4755979504489,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-111216852980,Term 20,,Term 19,,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,844523495741,Term 20,,Term 19,,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 21,861127851880,Term 20,813101140024,Term 19,788173092234,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,844523495741,Term 20,,Term 19,,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 21,16604356139,Term 20,15472467145,Term 19,10075385067,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 21,18774536960,Term 20,18549466745,Term 19,-11691231674,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 21,258833414,Term 20,237005392,Term 19,-585451313,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,18515703546,Term 20,18312461353,Term 19,-11105780361,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,18515703546,Term 20,18312461353,Term 19,-11105780361,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 21,-149661927,Term 20,-1327783683,Term 19,-1906910378,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,,Term 20,2748411,Term 19,44993850,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,234458815,Term 20,-215096850,Term 19,88177739,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 21,60934665619,Term 20,-27173924263,Term 19,27153141734,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,59542607547,Term 20,-26944089120,Term 19,26807333210,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 21,1392058072,Term 20,-229835143,Term 19,345808524,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,59542607547,Term 20,-26944089120,Term 19,26807333210,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 21,,Term 20,12000000000,Term 19,3280153811,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,184421296950,Term 20,,Term 19,,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 21,-107863441906,Term 20,5592780295,Term 19,-415352607,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,,Term 20,,Term 19,-421708533,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-106214656931,Term 20,6210148270,Term 19,-1838272077,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,-106214656931,Term 20,6210148270,Term 19,-2259980610,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 21,-1648784975,Term 20,-617367975,Term 19,1844628003,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 21,5497832811356,Term 20,4849195698865,Term 19,4237087665136,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 21,5388010154330,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 21,109822657026,Term 20,93216194376,Term 19,90353924957,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 21,-217431509911,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 21,97325737783,Term 20,97325737783,Term 19,97325737783,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 21,88589470000,Term 20,88589470000,Term 19,88589470000,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 21,5484022033744,Term 20,,Term 19,,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20220516002048,11011,2021,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 21,-64495577286,Term 20,,Term 19,-96636000943,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 22,2284388637755,Term 21,2472884295774,Term 20,1982768917805,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 22,655092563078,Term 21,734520611733,Term 20,434105464098,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 22,21974830400,Term 21,95352448800,Term 20,58536528000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentReceivables,기타채권,-,Term 22,602885508474,Term 21,592964794438,Term 20,637791666835,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermTradeReceivable,매출채권,-,Term 22,550861505948,Term 21,554857050527,Term 20,585564696288,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,-Standard account code not used-,기타채권,-,Term 22,52024002526,Term 21,38107743911,Term 20,52226970547,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 22,955432614662,Term 21,1000655942465,Term 20,808965987719,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 22,2687794247,Term 21,824675343,Term 20,373764592,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCurrentAssets,기타유동자산,-,Term 22,46315326894,Term 21,48565822995,Term 20,42995506561,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 22,5018541014448,Term 21,5082355121943,Term 20,4818646865905,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermDepositsNotClassifiedAsCashEquivalents,장기금융상품,-,Term 22,23000000,Term 21,20000000,Term 20,20000000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentReceivablesGross,장기기타채권,-,Term 22,40637972467,Term 21,49092915577,Term 20,50353958215,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates,관계기업및공동기업투자,-,Term 22,60146908565,Term 21,59167859842,Term 20,59998748118,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 22,52397079036,Term 21,38593929168,Term 20,38749519773,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 22,2383867277039,Term 21,2449112181346,Term 20,2329834013415,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 22,180820799447,Term 21,204288160278,Term 20,219793014823,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 22,25933611138,Term 21,30129279961,Term 20,24759532927,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsOtherThanGoodwill,무형자산,-,Term 22,2100587252176,Term 21,2168719935017,Term 20,2063442867186,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 22,64367260770,Term 21,28409958922,Term 20,9768003713,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherNonCurrentAssets,기타비유동자산,-,Term 22,109759853810,Term 21,54820901832,Term 20,21927207735,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 22,7302929652203,Term 21,7555239417717,Term 20,6801415783710,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 22,1162757522705,Term 21,1525844759254,Term 20,1479723875311,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayables,매입채무 및 기타유동채무,-,Term 22,678040436130,Term 21,862367973560,Term 20,779910998828,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_ShortTermTradePayables,단기매입채무,-,Term 22,213187479186,Term 21,270571519551,Term 20,251186196633,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,-Standard account code not used-,기타채무,-,Term 22,241803567987,Term 21,299660142515,Term 20,338733244659,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 22,215544469417,Term 21,256676145850,Term 20,186412985536,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 22,7504919540,Term 21,5460181804,Term 20,3578572000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CurrentPortionOfBonds,유동성사채,-,Term 22,0,Term 21,29999983840,Term 20,0,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 22,102379416709,Term 21,188801478806,Term 20,180411503449,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CurrentProvisionsForReturnedGoods,유동반품충당부채,-,Term 22,13339134213,Term 21,12875692276,Term 20,15621411384,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 22,248426155665,Term 21,330577242027,Term 20,349310770860,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCurrentLiabilities,기타유동부채,-,Term 22,120572379988,Term 21,131222372585,Term 20,154469190790,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 22,671336141249,Term 21,531561847107,Term 20,472496209534,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermTradeAndOtherNonCurrentPayables,장기매입채무 및 기타비유동채무,-,Term 22,24984549756,Term 21,21237095226,Term 20,57308752150,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermBorrowingsGross,장기차입금,-,Term 22,14783780077,Term 21,17341601617,Term 20,22801783421,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_BondsIssued,사채,-,Term 22,0,Term 21,0,Term 20,29999854078,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdings,장기예수보증금,-,Term 22,10200769679,Term 21,3895493609,Term 20,4507114651,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_PostemploymentBenefitObligations,퇴직급여부채,-,Term 22,63616144843,Term 21,51421810319,Term 20,48752783196,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 22,165223257419,Term 21,121735464959,Term 20,131795665327,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 22,375094983970,Term 21,263149536421,Term 20,157269496925,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherNonCurrentLiabilities,기타비유동부채,-,Term 22,42417205261,Term 21,74017940182,Term 20,77369511936,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 22,1834093663954,Term 21,2057406606361,Term 20,1952220084845,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유지분,-,Term 22,5339282549902,Term 21,5388010154330,Term 20,4755979504489,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금(결손금),-,Term 22,5542446884994,Term 21,5484022033744,Term 20,4805404131407,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherComprehensiveIncomeLossAccumulatedAmount,기타포괄손익누계액,-,Term 22,-83209267310,Term 21,-64495577286,Term 20,-124122981721,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,dart_OtherCapitalAdjustments,기타자본항목,-,Term 22,-305870275565,Term 21,-217431509911,Term 20,-111216852980,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 22,129553438347,Term 21,109822657026,Term 20,93216194376,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 22,5468835988249,Term 21,5497832811356,Term 20,4849195698865,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,자본과부채총계,-,Term 22,7302929652203,Term 21,7555239417717,Term 20,6801415783710,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 22,7185759184335,Term 21,8091511297961,Term 20,7844506057131,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 22,3168512092765,Term 21,3039883555040,Term 20,2962930553558,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 22,4017247091570,Term 21,5051627742921,Term 20,4881575503573,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_TotalSellingGeneralAdministrativeExpenses,판매비와관리비,-,Term 22,3306124157201,Term 21,3761997319316,Term 20,3660710772262,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익(손실),-,Term 22,711122934369,Term 21,1289630423605,Term 20,1220864731311,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 22,21588027756,Term 21,9572005157,Term 20,15434807035,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 22,27261631668,Term 21,22886303361,Term 20,21616953222,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 22,58855764285,Term 21,54382716863,Term 20,44819578890,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 22,353493663488,Term 21,148406751184,Term 20,145452166970,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,-Standard account code not used-,지분법손익,-,Term 22,6957929498,Term 21,5072767505,Term 20,7024275269,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익(손실),-,Term 22,417769360752,Term 21,1187364858585,Term 20,1121074272313,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 22,159429313871,Term 21,326237006705,Term 20,307973132289,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 22,21767621073,Term 21,16604356139,Term 20,15472467145,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 및 희석 보통주당이익,-,Term 22,14112,Term 21,50395,Term 20,47596,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,기본 및 희석 우선주당이익,-,Term 22,14162,Term 21,50445,Term 20,47647,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 22,7014594733,Term 21,79793999467,Term 20,-10164589640,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 22,24289540593,Term 21,18624875033,Term 20,17224431473,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 22,24289767415,Term 21,18774536960,Term 20,18549466745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,-,Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,-,Term 22,197100000,Term 21,0,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,당기손익으로 재분류될 수 있는 항목(세후기타포괄손익),-,Term 22,-17274945860,Term 21,61169124434,Term 20,-27389021113,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,dart_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법 적용대상 관계기업과 공동기업의 기타포괄손익에 대한 지분(세후기타포괄손익),-,Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업장환산외환차이(세후기타포괄손익),-,Term 22,-17296890609,Term 21,60934665619,Term 20,-27173924263,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄손익,-,Term 22,265354641614,Term 21,940921851347,Term 20,802936550384,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 22,240888502176,Term 21,922666603722,Term 20,787456912990,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 22,24466139438,Term 21,18255247625,Term 20,15479637394,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동현금흐름,-,Term 22,497299483100,Term 21,984481666368,Term 20,1004842472035,0,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProfitLossForStatementOfCashFlows,당기순이익(손실),-,Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 22,678770999043,Term 21,655594377448,Term 20,626194542524,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDepreciationExpense,감가상각비,-,Term 22,246887613016,Term 21,240917419595,Term 20,233925508629,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 22,41092465637,Term 21,34129748348,Term 20,28295853267,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 22,48421103671,Term 21,50413856656,Term 20,50474494996,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비,-,Term 22,-428896863,Term 21,3729253285,Term 20,595482883,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 22,14830609188,Term 21,12537198896,Term 20,12507879942,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 22,5088997246,Term 21,1233674337,Term 20,2555055538,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가손실,-,Term 22,6732536253,Term 21,4921968498,Term 20,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가손실,-,Term 22,0,Term 21,1380318713,Term 20,2431280464,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 평가이익,-,Term 22,-4632564558,Term 21,-1582418788,Term 20,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융부채 평가이익,-,Term 22,0,Term 21,-255798240,Term 20,-3205933336,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,당기손익-공정가치 측정 금융자산 처분손실,-,Term 22,0,Term 21,0,Term 20,22428828,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 22,3417665095,Term 21,4947235977,Term 20,7796049548,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 22,36425687,Term 21,0,Term 20,122712135,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 22,3010429856,Term 21,700100092,Term 20,1179758364,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 22,61581730,Term 21,87136919,Term 20,12559557,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 22,6796472886,Term 21,3695340823,Term 20,958695011,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,투자부동산손상차손,-,Term 22,0,Term 21,0,Term 20,2723414919,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 22,177834742877,Term 21,563290248,Term 20,56925461,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 22,12183534981,Term 21,338700185,Term 20,0,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 22,159429313871,Term 21,326237006705,Term 20,307973132289,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestIncome,이자수익,-,Term 22,11331601645,Term 21,5680872283,Term 20,4984491548,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,배당금수익,-,Term 22,0,Term 21,-186600000,Term 20,-933000000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타의 대손상각비,-,Term 22,-197792932,Term 21,-1135147924,Term 20,120354050,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 22,3011356217,Term 21,1645379301,Term 20,1444637923,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentsInAssociates,종속기업/관계기업/공동기업투자처분이익,-,Term 22,38088456,Term 21,6259434084,Term 20,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 22,20139865677,Term 21,7882228803,Term 20,3539815333,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 22,146808846,Term 21,424275509,Term 20,3740590000,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 22,93183291,Term 21,31400000,Term 20,466778724,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 22,74404968,Term 21,50260469,Term 20,217521224,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 22,6957929498,Term 21,5072767505,Term 20,7024275269,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 22,0,Term 21,31288923,Term 20,0,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로인한자산ㆍ부채의변동,-,Term 22,-199657616423,Term 21,-232237308874,Term 20,-97771906662,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 22,12853602709,Term 21,48830535465,Term 20,22475967366,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInTradeAndOtherReceivables,기타채권,-,Term 22,-11283101681,Term 21,7439955809,Term 20,4352829222,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 22,62013447364,Term 21,-147805686623,Term 20,-67826527783,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 22,11453506140,Term 21,3246409858,Term 20,12117381977,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동자산,-,Term 22,-3913036948,Term 21,-5825558786,Term 20,-7901977197,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 22,-65158003482,Term 21,5129900386,Term 20,-30067851787,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInTradeAndOtherPayables,기타채무,-,Term 22,-49816791137,Term 21,-31106874116,Term 20,22469667835,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,환불부채,-,Term 22,481980735,Term 21,-3017943114,Term 20,-549255134,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 22,-72237655740,Term 21,-12476452211,Term 20,-12986505720,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 22,-33973949285,Term 21,-33517901510,Term 20,-8576068399,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInWithholdingsBanks,예수보증금,-,Term 22,5859634835,Term 21,-1293303890,Term 20,-554689404,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직금의 지급,-,Term 22,5830223526,Term 21,4891083551,Term 20,7374041609,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInPostemploymentBenefitObligations,퇴직급여부채의 관계사 전입,-,Term 22,129783254,Term 21,561746152,Term 20,825666713,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInFairValueOfPlanAssets,사외적립자산의 기여,-,Term 22,-44570790774,Term 21,-55921334529,Term 20,-54936455806,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 22,-5666018887,Term 21,-1589718214,Term 20,30759953064,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자수취(영업),-,Term 22,9693585964,Term 21,4850875119,Term 20,4959977013,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금수취(영업),-,Term 22,6013497709,Term 21,6384911352,Term 20,4227270000,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자지급(영업),-,Term 22,11779250888,Term 21,7982482336,Term 20,8700381507,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세납부(환급),-,Term 22,244081779186,Term 21,303256558221,Term 20,337168169357,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동현금흐름,-,Term 22,-197383721806,Term 21,-465122432772,Term 20,-745883641217,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 감소,-,Term 22,83471000000,Term 21,42000000000,Term 20,76200000999,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 감소,-,Term 22,4352892626,Term 21,7150005783,Term 20,894557167,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기금융상품의 감소,-,Term 22,0,Term 21,0,Term 20,4000000,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 감소,-,Term 22,3953324404,Term 21,2286461472,Term 20,9748658623,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 22,197100000,Term 21,0,Term 20,0,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타비유동금융자산의 감소,-,Term 22,0,Term 21,0,Term 20,1173000000,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInAssociates,관계기업에 대한 투자자산의 처분,-,Term 22,0,Term 21,16943803,Term 20,0,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 22,34405002695,Term 21,17970989609,Term 20,6797791333,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 22,576520000,Term 21,2360000000,Term 20,4760000000,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 22,4640939909,Term 21,270342552,Term 20,9906597662,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,정부보조금의 수취,-,Term 22,19110000,Term 21,253700000,Term 20,0,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,종속기업 처분으로 인한 순현금유입액,-,Term 22,0,Term 21,7364927342,Term 20,0,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기금융상품의 증가,-,Term 22,7200000000,Term 21,76229000000,Term 20,62500000000,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,단기기타채권의 증가,-,Term 22,751760126,Term 21,696100059,Term 20,178968162,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,장기기타채권의 증가,-,Term 22,2028968475,Term 21,4563158125,Term 20,3927857300,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,기타포괄손익-공정가치 측정 금융자산의 취득,-,Term 22,536445000,Term 21,0,Term 20,0,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 22,157045694758,Term 21,321874697496,Term 20,505743484068,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 22,0,Term 21,12528920,Term 20,0,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 22,9391190370,Term 21,10312236474,Term 20,13128703763,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금 유출,-,Term 22,152045552711,Term 21,131108082259,Term 20,269889233708,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동현금흐름,-,Term 22,-373633368656,Term 21,-238400403869,Term 20,-465737759835,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromShortTermBorrowings,단기차입금의 차입,-,Term 22,319949820109,Term 21,211508361822,Term 20,96944735692,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 22,5000000000,Term 21,0,Term 20,22736389421,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,종속기업의 유상증자,-,Term 22,0,Term 21,120000000,Term 20,0,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_RepaymentsOfShortTermBorrowings,단기차입금의 상환,-,Term 22,364155453328,Term 21,160451258420,Term 20,194202086120,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities,유동성장기차입금의 상환,-,Term 22,5708202529,Term 21,3578572000,Term 20,3567121000,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_RepaymentsOfBonds,유동성사채의 상환,-,Term 22,30000000000,Term 21,0,Term 20,100000000000,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 22,85831436888,Term 21,85093142807,Term 20,91236233038,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,종속기업투자의 취득,-,Term 22,11723995920,Term 21,14770273001,Term 20,0,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금지급,-,Term 22,201164100100,Term 21,186135519463,Term 20,196413444790,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,환율변동효과 반영전 현금및현금성자산의 순증가(감소),-,Term 22,-73717607362,Term 21,280958829727,Term 20,-206778929017,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초현금및현금성자산,-,Term 22,734520611733,Term 21,434105464098,Term 20,647104059171,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,현금및현금성자산에 대한 환율변동효과,-,Term 22,-77301,Term 21,325780165,Term 20,-300879719,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,-Standard account code not used-,해외사업환산차이,-,Term 22,-5710363992,Term 21,19130537743,Term 20,-5918786337,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말현금및현금성자산,-,Term 22,655092563078,Term 21,734520611733,Term 20,434105464098,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,5484022033744,Term 21,4805404131407,Term 20,4174881534589,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-64495577286,Term 21,-124122981721,Term 20,-96636000943,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 22,5497832811356,Term 21,4849195698865,Term 20,4237087665136,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|비지배지분 [member],Term 22,109822657026,Term 21,93216194376,Term 20,90353924957,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,5388010154330,Term 21,4755979504489,Term 20,4146733740179,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-217431509911,Term 21,-111216852980,Term 20,-117427001250,1,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 22,258340046881,Term 21,861127851880,Term 20,813101140024,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,236572425808,Term 21,844523495741,Term 20,797628672879,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [member]|비지배지분 [member],Term 22,21767621073,Term 21,16604356139,Term 20,15472467145,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,연결재무제표 [member],Term 22,24289767415,Term 21,18774536960,Term 20,18549466745,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|비지배지분 [member],Term 22,1457101023,Term 21,258833414,Term 20,237005392,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,22832666392,Term 21,18515703546,Term 20,18312461353,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,확정급여제도의 재측정요소,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,22832666392,Term 21,18515703546,Term 20,18312461353,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 평가손실,연결재무제표 [member],Term 22,-197326822,Term 21,-149661927,Term 20,-1327783683,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분이익,연결재무제표 [member],Term 22,197100000,Term 21,,Term 20,2748411,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,,Term 21,,Term 20,999988875,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,기타포괄손익 공정가치 측정 금융자산 처분으로 인한 재분류,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,,Term 21,,Term 20,-999988875,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,연결재무제표 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,-Standard account code not used-,지분법자본변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,21944749,Term 21,234458815,Term 20,-215096850,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,연결재무제표 [member],Term 22,-17296890609,Term 21,60934665619,Term 20,-27173924263,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|비지배지분 [member],Term 22,1241417342,Term 21,1392058072,Term 20,-229835143,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-18538307951,Term 21,59542607547,Term 20,-26944089120,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,dart_ChangesInForeignExchangeRates,해외사업환산손익,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-18538307951,Term 21,59542607547,Term 20,-26944089120,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,201177340950,Term 21,184421296950,Term 20,184421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|비지배지분 [member],Term 22,,Term 21,,Term 20,12000000000,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 22,201177340950,Term 21,184421296950,Term 20,196421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,201177340950,Term 21,184421296950,Term 20,184421296950,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-88438765654,Term 21,-106214656931,Term 20,6210148270,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,-88438765654,Term 21,-106214656931,Term 20,6210148270,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,자본 [member]|비지배지분 [member],Term 22,-4735358117,Term 21,-1648784975,Term 20,-617367975,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl,비지배지분의 변동,연결재무제표 [member],Term 22,-93174123771,Term 21,-107863441906,Term 20,5592780295,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본잉여금 [member],Term 22,97325737783,Term 21,97325737783,Term 20,97325737783,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|자본금 [member],Term 22,88589470000,Term 21,88589470000,Term 20,88589470000,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|이익잉여금 [member],Term 22,5542446884994,Term 21,5484022033744,Term 20,4805404131407,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타포괄손익누계액 [member],Term 22,-83209267310,Term 21,-64495577286,Term 20,-124122981721,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member]|기타자본항목,Term 22,-305870275565,Term 21,-217431509911,Term 20,-111216852980,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|지배기업의 소유주에게 귀속되는 자본 [member],Term 22,5339282549902,Term 21,5388010154330,Term 20,4755979504489,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,연결재무제표 [member],Term 22,5468835988249,Term 21,5497832811356,Term 20,4849195698865,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20230320000833,11011,2022,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,기말자본,자본 [member]|비지배지분 [member],Term 22,129553438347,Term 21,109822657026,Term 20,93216194376,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Assets,자산총계,-,Term 23,7220285811725,Term 22,7302929652203,Term 21,7555239417717,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 23,2429583603574,Term 22,2284388637755,Term 21,2472884295774,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 23,910348037982,Term 22,655092563078,Term 21,734520611733,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 23,529076344154,Term 22,550861505948,Term 21,554857050527,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 23,884515142151,Term 22,955432614662,Term 21,1000655942465,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 23,45271354734,Term 22,46315326894,Term 21,48565822995,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 23,5508065693,Term 22,2687794247,Term 21,824675343,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타채권,-,Term 23,38386687660,Term 22,52024002526,Term 21,38107743911,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 23,16477971200,Term 22,21974830400,Term 21,95352448800,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 23,4790702208151,Term 22,5018541014448,Term 21,5082355121943,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 23,34125353691,Term 22,52397079036,Term 21,38593929168,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 23,2007877629243,Term 22,2100587252176,Term 21,2168719935017,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업및공동기업투자,-,Term 23,61771210888,Term 22,60146908565,Term 21,59167859842,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 23,45974090552,Term 22,25933611138,Term 21,30129279961,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_LongtermDeposits,장기금융상품,-,Term 23,23000000,Term 22,23000000,Term 21,20000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 23,70587172824,Term 22,109759853810,Term 21,54820901832,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 23,79877043683,Term 22,64367260770,Term 21,28409958922,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,장기기타채권,-,Term 23,31032978196,Term 22,40637972467,Term 21,49092915577,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 23,2307114070178,Term 22,2383867277039,Term 21,2449112181346,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 23,152319658896,Term 22,180820799447,Term 21,204288160278,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Equity,자본총계,-,Term 23,5548926465800,Term 22,5468835988249,Term 21,5497832811356,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,5433451058889,Term 22,5339282549902,Term 21,5388010154330,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본항목,-,Term 23,-260224352418,Term 22,-305870275565,Term 21,-217431509911,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 23,-96665276609,Term 22,-83209267310,Term 21,-64495577286,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 23,5604425480133,Term 22,5542446884994,Term 21,5484022033744,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 23,115475406911,Term 22,129553438347,Term 21,109822657026,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본 총계,-,Term 23,7220285811725,Term 22,7302929652203,Term 21,7555239417717,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 23,1089658847771,Term 22,1162757522705,Term 21,1525844759254,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,단기차입금,-,Term 23,138182509535,Term 22,215544469417,Term 21,256676145850,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,유동성장기차입금,-,Term 23,7790336487,Term 22,7504919540,Term 21,5460181804,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued,유동성사채,-,Term 23,0,Term 22,0,Term 21,29999983840,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentRefundsProvision,환불부채,-,Term 23,11578946312,Term 22,13339134213,Term 21,12875692276,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 23,45524846342,Term 22,102379416709,Term 21,188801478806,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 23,309681059345,Term 22,248426155665,Term 21,330577242027,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타 유동부채,-,Term 23,96798747084,Term 22,120572379988,Term 21,131222372585,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타채무,-,Term 23,226704100602,Term 22,241803567987,Term 21,299660142515,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 23,253398302064,Term 22,213187479186,Term 21,270571519551,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채총계,-,Term 23,1671359345925,Term 22,1834093663954,Term 21,2057406606361,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 23,581700498154,Term 22,671336141249,Term 21,531561847107,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,-Standard account code not used-,예수보증금,-,Term 23,9741129137,Term 22,10200769679,Term 21,3895493609,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 23,147859534986,Term 22,165223257419,Term 21,121735464959,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentPortionOfNoncurrentLoansReceived,장기차입금,-,Term 23,1993443590,Term 22,14783780077,Term 21,17341601617,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,퇴직급여부채,-,Term 23,57381078977,Term 22,63616144843,Term 21,51421810319,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 23,317768045372,Term 22,375094983970,Term 21,263149536421,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타 비유동 부채,-,Term 23,46957266092,Term 22,42417205261,Term 21,74017940182,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익,-,Term 23,486981224742,Term 22,711122934369,Term 21,1289630423605,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 23,46582397077,Term 22,58855764285,Term 21,54382716863,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 23,274827614677,Term 22,353493663488,Term 21,148406751184,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 23,3177921081645,Term 22,3168512092765,Term 21,3039883555040,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,-Standard account code not used-,기본 우선주당이익,-,Term 23,8563,Term 22,14162,Term 21,50445,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,-Standard account code not used-,희석 우선주당이익,-,Term 23,8563,Term 22,14162,Term 21,50445,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본 보통주당이익,-,Term 23,8513,Term 22,14112,Term 21,50395,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,희석 보통주당이익,-,Term 23,8513,Term 22,14112,Term 21,50395,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 23,39052274245,Term 22,27261631668,Term 21,22886303361,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 23,48968915334,Term 22,21588027756,Term 21,9572005157,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 23,3626918288484,Term 22,4017247091570,Term 21,5051627742921,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 23,112859158403,Term 22,159429313871,Term 21,326237006705,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 23,20768740624,Term 22,21767621073,Term 21,16604356139,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 23,276383378383,Term 22,417769360752,Term 21,1187364858585,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 23,6804839370129,Term 22,7185759184335,Term 21,8091511297961,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 23,3139937063742,Term 22,3306124157201,Term 21,3761997319316,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,IS,Income statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 23,7730730152,Term 22,6957929498,Term 21,5072767505,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,총포괄이익,-,Term 23,136065139024,Term 22,265354641614,Term 21,940921851347,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 23,20413564234,Term 22,24466139438,Term 21,18255247625,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 23,115651574790,Term 22,240888502176,Term 21,922666603722,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 23,-27459080956,Term 22,7014594733,Term 21,79793999467,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되는 항목,-,Term 23,-12966067430,Term 22,-17274945860,Term 21,61169124434,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 23,-14468688939,Term 22,-17296890609,Term 21,60934665619,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,-,Term 23,1502621509,Term 22,21944749,Term 21,234458815,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목,-,Term 23,-14493013526,Term 22,24289540593,Term 21,18624875033,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,-,Term 23,-44771090,Term 22,-226822,Term 21,-149661927,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,-,Term 23,-14448242436,Term 22,24289767415,Term 21,18774536960,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 23,655092563078,Term 22,734520611733,Term 21,434105464098,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 23,910348037982,Term 22,655092563078,Term 21,734520611733,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 23,-268201685330,Term 22,-373633368656,Term 21,-238400403869,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PaymentForConsolidatedCapitalTransactions,연결자본거래로 인한 변동,-,Term 23,12182000,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유입액,-,Term 23,68752436418,Term 22,324949820109,Term 21,211628361822,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유출액,-,Term 23,336954121748,Term 22,698583188765,Term 21,450028765691,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금의 수령,-,Term 23,2281004811,Term 22,0,Term 21,0,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,장기차입금의 차입,-,Term 23,0,Term 22,5000000000,Term 21,0,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,유동성장기차입금의 상환,-,Term 23,12504919540,Term 22,5708202529,Term 21,3578572000,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금의 지급,-,Term 23,2285992867,Term 22,0,Term 21,0,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 23,97124600150,Term 22,201164100100,Term 21,186135519463,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,비지배지분의 취득,-,Term 23,0,Term 22,11723995920,Term 21,14770273001,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 23,77523016101,Term 22,85831436888,Term 21,85093142807,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromContributionsOfNoncontrollingInterests,종속기업의 유상증자,-,Term 23,0,Term 22,0,Term 21,120000000,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 차입,-,Term 23,66471431607,Term 22,319949820109,Term 21,211508361822,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBondsNotesAndDebentures,유동성사채의 상환,-,Term 23,0,Term 22,30000000000,Term 21,0,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 상환,-,Term 23,147503411090,Term 22,364155453328,Term 21,160451258420,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 23,-140774747630,Term 22,-197383721806,Term 21,-465122432772,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 감소,-,Term 23,147444361,Term 22,0,Term 21,0,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 23,0,Term 22,197100000,Term 21,0,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInSubsidiaries,종속기업 처분으로 인한 순현금유입액,-,Term 23,0,Term 22,0,Term 21,7364927342,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermLoansAndReceivables,장기기타채권의 감소,-,Term 23,13569453414,Term 22,3953324404,Term 21,2286461472,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산의 처분,-,Term 23,10607576553,Term 22,0,Term 21,0,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,단기금융상품의 감소,-,Term 23,5518167924,Term 22,83471000000,Term 21,42000000000,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermLoansAndReceivables,단기기타채권의 감소,-,Term 23,2003884990,Term 22,4352892626,Term 21,7150005783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 취득,-,Term 23,1406880000,Term 22,0,Term 21,0,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치측정금융자산의취득,-,Term 23,0,Term 22,536445000,Term 21,0,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfLongTermLoansAndReceivables,장기기타채권의 증가,-,Term 23,2495184656,Term 22,2028968475,Term 21,4563158125,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,단기금융상품의 증가,-,Term 23,0,Term 22,7200000000,Term 21,76229000000,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermLoansAndReceivables,단기기타채권의 증가,-,Term 23,891463446,Term 22,751760126,Term 21,696100059,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출액,-,Term 23,42226006685,Term 22,152045552711,Term 21,131108082259,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유입액,-,Term 23,69758341538,Term 22,131615889634,Term 21,79673370561,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities,공동기업투자의 처분,-,Term 23,4472515425,Term 22,0,Term 21,16943803,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_OutflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유출액,-,Term 23,210533089168,Term 22,328999611440,Term 21,544795803333,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,국고보조금의 수취,-,Term 23,297900000,Term 22,19110000,Term 21,253700000,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 23,798429624,Term 22,4640939909,Term 21,270342552,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 23,10078205814,Term 22,576520000,Term 21,2360000000,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 23,22264763433,Term 22,34405002695,Term 21,17970989609,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 23,11095215663,Term 22,9391190370,Term 21,10312236474,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfInvestmentProperty,투자부동산의 취득,-,Term 23,0,Term 22,0,Term 21,12528920,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 23,152418338718,Term 22,157045694758,Term 21,321874697496,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 23,659061627244,Term 22,497299483100,Term 21,984481666368,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로 인한 자산부채의 변동,-,Term 23,113424453984,Term 22,-199657616423,Term 21,-232237308874,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 23,-3529410936,Term 22,-3913036948,Term 21,-5825558786,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 23,5973809642,Term 22,-5666018887,Term 21,-1589718214,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInProvisionsForReturnedGoods,환불부채,-,Term 23,-1781499741,Term 22,481980735,Term 21,-3017943114,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 23,45642050773,Term 22,-72237655740,Term 21,-12476452211,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직급여부채의 관계사 전입,-,Term 23,63983179,Term 22,129783254,Term 21,561746152,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금,-,Term 23,34324,Term 22,5859634835,Term 21,-1293303890,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 23,75399386528,Term 22,62013447364,Term 21,-147805686623,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 23,7783706027,Term 22,11453506140,Term 21,3246409858,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables,기타채권,-,Term 23,12235677287,Term 22,-11283101681,Term 21,7439955809,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 23,23545052313,Term 22,12853602709,Term 21,48830535465,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 23,-27241015124,Term 22,-33973949285,Term 21,-33517901510,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables,기타채무,-,Term 23,-30530710825,Term 22,-49816791137,Term 21,-31106874116,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 23,39379494117,Term 22,-65158003482,Term 21,5129900386,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset,사외적립자산,-,Term 23,26599447041,Term 22,44570790774,Term 21,55921334529,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset,퇴직금의 지급,-,Term 23,6916656539,Term 22,5830223526,Term 21,4891083551,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의가감,-,Term 23,536269020585,Term 22,678770999043,Term 21,655594377448,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비(대손충당금환입),-,Term 23,1294475720,Term 22,-428896863,Term 21,3729253285,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForBargainPurchaseGains,염가매수차익,-,Term 23,0,Term 22,0,Term 21,31288923,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 23,12574109819,Term 22,20139865677,Term 21,7882228803,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 23,2168413249,Term 22,3011356217,Term 21,1645379301,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 23,138768242,Term 22,93183291,Term 21,31400000,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 23,4648837954,Term 22,146808846,Term 21,424275509,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산처분이익,-,Term 23,2775048994,Term 22,0,Term 21,0,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 23,18722387548,Term 22,4632564558,Term 21,1582418788,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 23,112204887141,Term 22,177834742877,Term 21,563290248,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 23,6555409177,Term 22,6796472886,Term 21,3695340823,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 23,19366715671,Term 22,14830609188,Term 21,12537198896,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 23,6390206970,Term 22,3010429856,Term 21,700100092,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 23,10751933,Term 22,36425687,Term 21,0,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 23,9405747018,Term 22,3417665095,Term 21,4947235977,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 23,14582257107,Term 22,6732536253,Term 21,4921968498,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 23,3588155054,Term 22,5088997246,Term 21,1233674337,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 23,43856005073,Term 22,48421103671,Term 21,50413856656,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_AdjustmentsForReversalsOfBadDebtExpenses,기타대손충당금환입,-,Term 23,181795254,Term 22,197792932,Term 21,1135147924,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnDisposalsOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산 처분이익,-,Term 23,3016089,Term 22,0,Term 21,0,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnSaleOfInvestmentsInSubsidiaries,종속기업처분이익,-,Term 23,0,Term 22,38088456,Term 21,6259434084,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_GainsOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가이익,-,Term 23,0,Term 22,0,Term 21,255798240,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_ImpairmentLossesOnInvestmentProperty,투자부동산손상차손,-,Term 23,896541999,Term 22,0,Term 21,0,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,dart_LossesOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가손실,-,Term 23,5481920,Term 22,0,Term 21,1380318713,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 23,3395246737,Term 22,74404968,Term 21,50260469,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 23,242452048,Term 22,61581730,Term 21,87136919,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,공동기업처분이익,-,Term 23,2062573050,Term 22,0,Term 21,0,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 23,16070474902,Term 22,12183534981,Term 21,338700185,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 23,37773195056,Term 22,41092465637,Term 21,34129748348,92,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,감가상각비,-,Term 23,232093988438,Term 22,246887613016,Term 21,240917419595,93,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 23,112859158403,Term 22,159429313871,Term 21,326237006705,94,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 23,26357835957,Term 22,11331601645,Term 21,5680872283,95,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_RevenueFromDividends,배당금수익,-,Term 23,168120000,Term 22,0,Term 21,186600000,96,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 23,7730730152,Term 22,6957929498,Term 21,5072767505,97,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 23,5895060000,Term 22,6013497709,Term 21,6384911352,98,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 23,166490102118,Term 22,244081779186,Term 21,303256558221,99,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 23,16147404861,Term 22,11779250888,Term 21,7982482336,100,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 23,22586379674,Term 22,9693585964,Term 21,4850875119,101,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익(손실),-,Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,102,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 변동,-,Term 23,5170280620,Term 22,-5710441293,Term 21,19456317908,103,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금및현금성자산의 증가(감소),-,Term 23,250085194284,Term 22,-73717607362,Term 21,280958829727,104,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 23,5468835988249,Term 22,5497832811356,Term 21,4849195698865,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 23,129553438347,Term 22,109822657026,Term 21,93216194376,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,5339282549902,Term 22,5388010154330,Term 21,4755979504489,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,-305870275565,Term 22,-217431509911,Term 21,-111216852980,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-83209267310,Term 22,-64495577286,Term 21,-124122981721,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,5542446884994,Term 22,5484022033744,Term 21,4805404131407,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,67128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|비지배지분 [구성요소],Term 23,30000000000,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 23,97128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,67128988950,Term 22,201177340950,Term 21,184421296950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,연결재무제표 [member],Term 23,5548926465800,Term 22,5468835988249,Term 21,5497832811356,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|비지배지분 [구성요소],Term 23,115475406911,Term 22,129553438347,Term 21,109822657026,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,5433451058889,Term 22,5339282549902,Term 21,5388010154330,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,88589470000,Term 22,88589470000,Term 21,88589470000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,5604425480133,Term 22,5542446884994,Term 21,5484022033744,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-96665276609,Term 22,-83209267310,Term 21,-64495577286,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,-260224352418,Term 22,-305870275565,Term 21,-217431509911,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,97325737783,Term 22,97325737783,Term 21,97325737783,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,45645923147,Term 22,-88438765654,Term 21,-106214656931,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|비지배지분 [구성요소],Term 23,-4491595670,Term 22,-4735358117,Term 21,-1648784975,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,연결재무제표 [member],Term 23,41154327477,Term 22,-93174123771,Term 21,-107863441906,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,45645923147,Term 22,-88438765654,Term 21,-106214656931,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동 등,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-14905028256,Term 22,-18538307951,Term 21,59542607547,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 23,436339317,Term 22,1241417342,Term 21,1392058072,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 23,-14468688939,Term 22,-17296890609,Term 21,60934665619,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-14905028256,Term 22,-18538307951,Term 21,59542607547,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-45654236,Term 22,-226822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 23,883146,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,연결재무제표 [member],Term 23,-44771090,Term 22,-226822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,7948316,Term 22,197100000,Term 21,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,-53602552,Term 22,-197326822,Term 21,-149661927,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,연결재무제표 [member],Term 23,-14448242436,Term 22,24289767415,Term 21,18774536960,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|비지배지분 [구성요소],Term 23,-792398853,Term 22,1457101023,Term 21,258833414,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,-13655843583,Term 22,22832666392,Term 21,18515703546,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,-13655843583,Term 22,22832666392,Term 21,18515703546,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정요소,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),연결재무제표 [member],Term 23,163524219980,Term 22,258340046881,Term 21,861127851880,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|비지배지분 [구성요소],Term 23,20768740624,Term 22,21767621073,Term 21,16604356139,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,142755479356,Term 22,236572425808,Term 21,844523495741,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익(손실),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,연결재무제표 [member],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|비지배지분 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 23,1502621509,Term 22,21944749,Term 21,234458815,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20240318000511,11011,2023,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 23,0,Term 22,0,Term 21,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Assets,자산 총계,-,Term 24,7405784092201,Term 23,7220285811725,Term 22,7302929652203,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentAssets,유동자산,-,Term 24,2856048500735,Term 23,2429583603574,Term 22,2284388637755,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CashAndCashEquivalents,현금및현금성자산,-,Term 24,1253469878367,Term 23,910348037982,Term 22,655092563078,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentTradeReceivables,매출채권,-,Term 24,576205113721,Term 23,529076344154,Term 22,550861505948,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Inventories,재고자산,-,Term 24,922418157031,Term 23,884515142151,Term 22,955432614662,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentAssets,기타유동자산,-,Term 24,52465237154,Term 23,45271354734,Term 22,46315326894,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialAssets,기타유동금융자산,-,Term 24,4352814406,Term 23,5508065693,Term 22,2687794247,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentReceivables,기타채권,-,Term 24,30655383256,Term 23,38386687660,Term 22,52024002526,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents,단기금융상품,-,Term 24,16481916800,Term 23,16477971200,Term 22,21974830400,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentAssets,비유동자산,-,Term 24,4549735591466,Term 23,4790702208151,Term 22,5018541014448,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxAssets,이연법인세자산,-,Term 24,34730969596,Term 23,34125353691,Term 22,52397079036,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_IntangibleAssetsAndGoodwill,무형자산,-,Term 24,1964277226876,Term 23,2007877629243,Term 22,2100587252176,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_InvestmentAccountedForUsingEquityMethod,관계기업및공동기업투자,-,Term 24,57876225470,Term 23,61771210888,Term 22,60146908565,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_InvestmentProperty,투자부동산,-,Term 24,65194503689,Term 23,45974090552,Term 22,25933611138,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_LongtermDeposits,장기금융상품,-,Term 24,23000000,Term 23,23000000,Term 22,23000000,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentAssets,기타비유동자산,-,Term 24,18090955028,Term 23,70587172824,Term 22,109759853810,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialAssets,기타비유동금융자산,-,Term 24,31966761345,Term 23,79877043683,Term 22,64367260770,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentReceivables,장기기타채권,-,Term 24,28572485130,Term 23,31032978196,Term 22,40637972467,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_PropertyPlantAndEquipment,유형자산,-,Term 24,2226368549375,Term 23,2307114070178,Term 22,2383867277039,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_RightofuseAssets,사용권자산,-,Term 24,122634914957,Term 23,152319658896,Term 22,180820799447,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Equity,자본 총계,-,Term 24,5685920091079,Term 23,5548926465800,Term 22,5468835988249,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_EquityAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,5566264371939,Term 23,5433451058889,Term 22,5339282549902,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_CapitalSurplus,자본잉여금,-,Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_ElementsOfOtherStockholdersEquity,기타자본항목,-,Term 24,-297701911404,Term 23,-260224352418,Term 22,-305870275565,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_AccumulatedOtherComprehensiveIncome,기타포괄손익누계액,-,Term 24,-17528901762,Term 23,-96665276609,Term 22,-83209267310,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_IssuedCapital,자본금,-,Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_RetainedEarnings,이익잉여금,-,Term 24,5695579977322,Term 23,5604425480133,Term 22,5542446884994,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncontrollingInterests,비지배지분,-,Term 24,119655719140,Term 23,115475406911,Term 22,129553438347,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_EquityAndLiabilities,부채와 자본 총계,-,Term 24,7405784092201,Term 23,7220285811725,Term 22,7302929652203,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentLiabilities,유동부채,-,Term 24,1295900316472,Term 23,1089658847771,Term 22,1162757522705,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentPortionOfLongtermBorrowings,유동성장기차입금,-,Term 24,1993443590,Term 23,7790336487,Term 22,7504919540,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentRefundsProvision,환불부채,-,Term 24,12165316348,Term 23,11578946312,Term 22,13339134213,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_CurrentTaxLiabilities,당기법인세부채,-,Term 24,66915906521,Term 23,45524846342,Term 22,102379416709,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 24,470505326911,Term 23,309681059345,Term 22,248426155665,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentLiabilities,기타유동부채,-,Term 24,72481574932,Term 23,96798747084,Term 22,120572379988,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherCurrentPayables,기타채무,-,Term 24,199506237169,Term 23,226704100602,Term 22,241803567987,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_ShorttermBorrowings,단기차입금,-,Term 24,241330029491,Term 23,138182509535,Term 22,215544469417,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers,매입채무,-,Term 24,231002481510,Term 23,253398302064,Term 22,213187479186,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_Liabilities,부채 총계,-,Term 24,1719864001122,Term 23,1671359345925,Term 22,1834093663954,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentLiabilities,비유동부채,-,Term 24,423963684650,Term 23,581700498154,Term 22,671336141249,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,dart_LongTermGuaranteeDepositWithholdingsNet,예수보증금,-,Term 24,5816707551,Term 23,9741129137,Term 22,10200769679,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_DeferredTaxLiabilities,이연법인세부채,-,Term 24,127838780237,Term 23,147859534986,Term 22,165223257419,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_LongtermBorrowings,장기차입금,-,Term 24,0,Term 23,1993443590,Term 22,14783780077,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan,퇴직급여부채,-,Term 24,61140758953,Term 23,57381078977,Term 22,63616144843,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentFinancialLiabilities,기타비유동금융부채,-,Term 24,178369594748,Term 23,317768045372,Term 22,375094983970,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,BS,Statement of financial position,ifrs-full_OtherNoncurrentLiabilities,기타비유동부채,-,Term 24,50797843161,Term 23,46957266092,Term 22,42417205261,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OperatingIncomeLoss,영업이익,-,Term 24,459045912180,Term 23,486981224742,Term 22,711122934369,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OtherGains,기타영업외수익,-,Term 24,26395321490,Term 23,46582397077,Term 22,58855764285,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_OtherLosses,기타영업외비용,-,Term 24,215484387559,Term 23,274827614677,Term 22,353493663488,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_CostOfSales,매출원가,-,Term 24,3251086359896,Term 23,3177921081645,Term 22,3168512092765,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_BasicEarningsLossPerSharePreferredStock,기본 우선주당이익,-,Term 24,11331,Term 23,8563,Term 22,14162,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,dart_DilutedEarningsLossPerSharePreferredStock,희석 우선주당이익,-,Term 24,11331,Term 23,8563,Term 22,14162,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_BasicEarningsLossPerShare,기본주당이익(단위: 원),-,Term 24,11281,Term 23,8513,Term 22,14112,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_DilutedEarningsLossPerShare,희석주당이익(단위: 원),-,Term 24,11281,Term 23,8513,Term 22,14112,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_FinanceCosts,금융원가,-,Term 24,21136677993,Term 23,39052274245,Term 22,27261631668,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_FinanceIncome,금융수익,-,Term 24,62038101402,Term 23,48968915334,Term 22,21588027756,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_GrossProfit,매출총이익,-,Term 24,3560832396845,Term 23,3626918288484,Term 22,4017247091570,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_IncomeTaxExpenseContinuingOperations,법인세비용,-,Term 24,112748613963,Term 23,112859158403,Term 22,159429313871,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToNoncontrollingInterests,비지배지분,-,Term 24,14752971711,Term 23,20768740624,Term 22,21767621073,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ProfitLossBeforeTax,법인세비용차감전순이익,-,Term 24,316636344102,Term 23,276383378383,Term 22,417769360752,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_Revenue,매출액,-,Term 24,6811918756741,Term 23,6804839370129,Term 22,7185759184335,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_SellingGeneralAndAdministrativeExpense,판매비와관리비,-,Term 24,3101786484665,Term 23,3139937063742,Term 22,3306124157201,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,IS,Income statement,ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 24,5778074582,Term 23,7730730152,Term 22,6957929498,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncome,당기총포괄이익,-,Term 24,250885696445,Term 23,136065139024,Term 22,265354641614,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests,비지배지분,-,Term 24,21843857459,Term 23,20413564234,Term 22,24466139438,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent,지배기업소유주지분,-,Term 24,229041838986,Term 23,115651574790,Term 22,240888502176,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncome,기타포괄손익,-,Term 24,46997966306,Term 23,-27459080956,Term 22,7014594733,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되는 항목,-,Term 24,87663490249,Term 23,-12966067430,Term 22,-17274945860,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax,해외사업환산손익,-,Term 24,87663490249,Term 23,-14468688939,Term 22,-17296890609,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,-,Term 24,0,Term 23,1502621509,Term 22,21944749,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax,후속적으로 당기손익으로 재분류되지 않는 항목:,-,Term 24,-40665523943,Term 23,-14493013526,Term 22,24289540593,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,-,Term 24,-420661737,Term 23,-44771090,Term 22,-226822,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),-,Term 24,-40244862206,Term 23,-14448242436,Term 22,24289767415,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CIS,Statement of comprehensive income,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtBeginningOfPeriodCf,기초의 현금및현금성자산,-,Term 24,910348037982,Term 23,655092563078,Term 22,734520611733,2,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_CashAndCashEquivalentsAtEndOfPeriodCf,기말의 현금및현금성자산,-,Term 24,1253469878367,Term 23,910348037982,Term 22,655092563078,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInFinancingActivities,재무활동으로 인한 현금흐름,-,Term 24,-53379075866,Term 23,-268201685330,Term 22,-373633368656,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_DecreaseInGuaranteeDepositsAsFinancialActivities,예수보증금의 지급,-,Term 24,153100000,Term 23,2285992867,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_IncreaseInGuaranteeDepositsAsFinancialActivities,예수보증금의 수령,-,Term 24,0,Term 23,2281004811,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PaymentForConsolidatedCapitalTransactions,연결자본거래로 인한 변동,-,Term 24,0,Term 23,12182000,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromLongTermBorrowings,장기차입금의 차입,-,Term 24,0,Term 23,0,Term 22,5000000000,12,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유입액,-,Term 24,198034356560,Term 23,68752436418,Term 22,324949820109,13,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,재무활동으로 인한 현금유출액,-,Term 24,251413432426,Term 23,336954121748,Term 22,698583188765,14,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,유동성장기차입금의 상환,-,Term 24,7790336487,Term 23,12504919540,Term 22,5708202529,15,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_DividendsPaidClassifiedAsFinancingActivities,배당금의 지급,-,Term 24,59751585994,Term 23,97124600150,Term 22,201164100100,16,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromChangesInOwnershipInterestsInSubsidiaries,비지배지분의 취득,-,Term 24,120953000,Term 23,0,Term 22,11723995920,17,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities,리스부채의 지급,-,Term 24,71291069342,Term 23,77523016101,Term 22,85831436888,18,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromCurrentBorrowings,단기차입금의 차입,-,Term 24,198034356560,Term 23,66471431607,Term 22,319949820109,19,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfBondsNotesAndDebentures,유동성사채의 상환,-,Term 24,0,Term 23,0,Term 22,30000000000,20,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_RepaymentsOfCurrentBorrowings,단기차입금의 상환,-,Term 24,112306387603,Term 23,147503411090,Term 22,364155453328,21,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInInvestingActivities,투자활동으로 인한 현금흐름,-,Term 24,-152177113918,Term 23,-140774747630,Term 22,-197383721806,22,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 감소,-,Term 24,118000000,Term 23,147444361,Term 22,0,23,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 처분,-,Term 24,0,Term 23,0,Term 22,197100000,24,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfInvestmentsInJointVentures,공동기업의 처분,-,Term 24,0,Term 23,4472515425,Term 22,0,25,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfLongTermLoansAndReceivables,장기기타채권의 감소,-,Term 24,4669705611,Term 23,13569453414,Term 22,3953324404,26,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfNonCurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산의 처분,-,Term 24,0,Term 23,10607576553,Term 22,0,27,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermFinancialInstruments,단기금융상품의 감소,-,Term 24,7000000000,Term 23,5518167924,Term 22,83471000000,28,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ProceedsFromSalesOfShortTermLoansAndReceivables,단기기타채권의 감소,-,Term 24,831495113,Term 23,2003884990,Term 22,4352892626,29,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산의 증가,-,Term 24,5017415555,Term 23,1406880000,Term 22,0,30,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfFinancialAssetsAtFairValueThroughOtherComprehensiveIncome,기타포괄손익-공정가치 측정 금융자산의 증가,-,Term 24,0,Term 23,0,Term 22,536445000,31,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfLongTermLoansAndReceivables,장기기타채권의 증가,-,Term 24,2661720524,Term 23,2495184656,Term 22,2028968475,32,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermFinancialInstruments,단기금융상품의 증가,-,Term 24,7000000000,Term 23,0,Term 22,7200000000,33,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_PurchaseOfShortTermLoansAndReceivables,단기기타채권의 증가,-,Term 24,2587977443,Term 23,891463446,Term 22,751760126,34,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities,사업결합으로 인한 순현금유출액,-,Term 24,0,Term 23,42226006685,Term 22,152045552711,35,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유입액,-,Term 24,14384355031,Term 23,69758341538,Term 22,131615889634,36,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_OutflowsOfCashFromInvestingActivities,투자활동으로 인한 현금유출액,-,Term 24,166561468949,Term 23,210533089168,Term 22,328999611440,37,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities,국고보조금의 수취,-,Term 24,205398919,Term 23,297900000,Term 22,19110000,38,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 처분,-,Term 24,40363636,Term 23,798429624,Term 22,4640939909,39,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfInvestmentProperty,투자부동산의 처분,-,Term 24,0,Term 23,10078205814,Term 22,576520000,40,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 처분,-,Term 24,1519391752,Term 23,22264763433,Term 22,34405002695,41,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities,무형자산의 취득,-,Term 24,16151302648,Term 23,11095215663,Term 22,9391190370,42,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfInterestsInAssociates,관계기업의 취득,-,Term 24,2000000000,Term 23,0,Term 22,0,43,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities,유형자산의 취득,-,Term 24,131143052779,Term 23,152418338718,Term 22,157045694758,44,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_CashFlowsFromUsedInOperatingActivities,영업활동으로 인한 현금흐름,-,Term 24,527630110092,Term 23,659061627244,Term 22,497299483100,45,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForAssetsLiabilitiesOfOperatingActivities,영업활동으로 인한 자산부채의 변동,-,Term 24,-113977431746,Term 23,113424453984,Term 22,-199657616423,46,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForDecreaseincreaseInOtherNonCurrentNonFinancialAssets,기타비유동자산,-,Term 24,380051773,Term 23,-3529410936,Term 22,-3913036948,47,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInOtherNonCurrentLiabilities,기타비유동부채,-,Term 24,9155451419,Term 23,5973809642,Term 22,-5666018887,48,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreaseDecreaseInProvisionsForReturnedGoods,환불부채,-,Term 24,387088783,Term 23,-1781499741,Term 22,481980735,49,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForIncreasedecreaseInOtherCurrentFinancialLiabilities,기타유동금융부채,-,Term 24,16107593829,Term 23,45642050773,Term 22,-72237655740,50,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,퇴직급여부채의 관계사 전입,-,Term 24,474753186,Term 23,63983179,Term 22,129783254,51,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,예수보증금,-,Term 24,3695913,Term 23,34324,Term 22,5859634835,52,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInInventories,재고자산,-,Term 24,-3294746419,Term 23,75399386528,Term 22,62013447364,53,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherCurrentAssets,기타유동자산,-,Term 24,-285751635,Term 23,7783706027,Term 22,11453506140,54,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables,기타채권,-,Term 24,18080001759,Term 23,12235677287,Term 22,-11283101681,55,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable,매출채권,-,Term 24,-32512956032,Term 23,23545052313,Term 22,12853602709,56,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities,기타유동부채,-,Term 24,-27330313643,Term 23,-27241015124,Term 22,-33973949285,57,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables,기타채무,-,Term 24,-27625599793,Term 23,-30530710825,Term 22,-49816791137,58,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable,매입채무,-,Term 24,-33017881463,Term 23,39379494117,Term 22,-65158003482,59,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset,사외적립자산,-,Term 24,-29140665601,Term 23,-26599447041,Term 22,-44570790774,60,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset,퇴직금의 지급,-,Term 24,5358153822,Term 23,6916656539,Term 22,5830223526,61,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForReconcileProfitLoss,수익ㆍ비용의 가감,-,Term 24,512542970578,Term 23,536269020585,Term 22,678770999043,62,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForBadDebtExpenses,대손상각비(대손충당금환입),-,Term 24,713134900,Term 23,1294475720,Term 22,-428896863,63,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnDispositionOfTangibleAssets,유형자산처분이익,-,Term 24,1242248536,Term 23,12574109819,Term 22,20139865677,64,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainOnForeignExchangeTranslations,외화환산이익,-,Term 24,9249386201,Term 23,2168413249,Term 22,3011356217,65,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfIntangibleAssets,무형자산처분이익,-,Term 24,37363636,Term 23,138768242,Term 22,93183291,66,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfInvestmentProperty,투자부동산처분이익,-,Term 24,0,Term 23,4648837954,Term 22,146808846,67,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnDisposalsOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale,매각예정자산처분이익,-,Term 24,0,Term 23,2775048994,Term 22,0,68,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForGainsOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가이익,-,Term 24,19067544007,Term 23,18722387548,Term 22,4632564558,69,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfIntangibleAssets,무형자산손상차손,-,Term 24,93440164020,Term 23,112204887141,Term 22,177834742877,70,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForImpairmentLossesOfPropertyPlantAndEquipment,유형자산손상차손,-,Term 24,7184444737,Term 23,6555409177,Term 22,6796472886,71,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForInterestExpenses,이자비용,-,Term 24,17267275143,Term 23,19366715671,Term 22,14830609188,72,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfIntangibleAssets,무형자산처분손실,-,Term 24,1317475199,Term 23,6390206970,Term 22,3010429856,73,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDisposalsOfInvestmentProperty,투자부동산처분손실,-,Term 24,0,Term 23,10751933,Term 22,36425687,74,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnDispositionOfPropertyPlantAndEquipment,유형자산처분손실,-,Term 24,6396855172,Term 23,9405747018,Term 22,3417665095,75,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnEvaluationOfFairValueFinancialAssets,당기손익-공정가치 측정 금융자산 평가손실,-,Term 24,184733262,Term 23,14582257107,Term 22,6732536253,76,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForLossesOnForeignExchangeTranslations,외화환산손실,-,Term 24,19376426283,Term 23,3588155054,Term 22,5088997246,77,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherBadDebtExpenses,기타대손충당금환입,-,Term 24,-398129715,Term 23,-181795254,Term 22,-197792932,78,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForOtherExpenseByFunction,기타영업외비용,-,Term 24,568044465,Term 23,0,Term 22,0,79,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForProfitsOfAssociatesAndJointVenturesAccountedForUsingEquityMethod,지분법손익,-,Term 24,5778074582,Term 23,7730730152,Term 22,6957929498,80,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_AdjustmentsForProvisionForSeveranceIndemnities,퇴직급여,-,Term 24,44446120510,Term 23,43856005073,Term 22,48421103671,81,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_GainsOnDisposalsOfFairValueFinancialAsset,당기손익-공정가치 측정 금융자산 처분이익,-,Term 24,0,Term 23,3016089,Term 22,0,82,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_GainsOnSaleOfInvestmentsInSubsidiaries,종속기업처분이익,-,Term 24,0,Term 23,0,Term 22,38088456,83,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_ImpairmentLossesOnInvestmentProperty,투자부동산손상차손,-,Term 24,629291595,Term 23,896541999,Term 22,0,84,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,dart_LossesOnValuationOfFairValueFinancialLiabilities,당기손익-공정가치 측정 금융부채 평가손실,-,Term 24,0,Term 23,5481920,Term 22,0,85,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분이익,-,Term 24,123684429,Term 23,3395246737,Term 22,74404968,86,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산처분손실,-,Term 24,78774666,Term 23,242452048,Term 22,61581730,87,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,공동기업처분이익,-,Term 24,0,Term 23,2062573050,Term 22,0,88,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,-Standard account code not used-,사용권자산손상차손,-,Term 24,22067106551,Term 23,16070474902,Term 22,12183534981,89,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForAmortisationExpense,무형자산상각비,-,Term 24,34341000860,Term 23,37773195056,Term 22,41092465637,90,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDepreciationExpense,감가상각비,-,Term 24,221266864790,Term 23,232093988438,Term 22,246887613016,91,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForDividendIncome,배당금수익,-,Term 24,1781612,Term 23,168120000,Term 22,0,92,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForIncomeTaxExpense,법인세비용,-,Term 24,112748613962,Term 23,112859158403,Term 22,159429313871,93,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_AdjustmentsForInterestIncome,이자수익,-,Term 24,33585142819,Term 23,26357835957,Term 22,11331601645,94,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_DividendsReceivedClassifiedAsOperatingActivities,배당금의 수취,-,Term 24,11674841612,Term 23,5895060000,Term 22,6013497709,95,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities,법인세의 납부,-,Term 24,103530506202,Term 23,166490102118,Term 22,244081779186,96,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InterestPaidClassifiedAsOperatingActivities,이자의 지급,-,Term 24,18559777623,Term 23,16147404861,Term 22,11779250888,97,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_InterestReceivedClassifiedAsOperatingActivities,이자의 수취,-,Term 24,35592283334,Term 23,22586379674,Term 22,9693585964,98,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_ProfitLoss,당기순이익,-,Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,99,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents,외화환산으로 인한 현금및현금성자산의 변동,-,Term 24,21047920077,Term 23,5170280620,Term 22,-5710441293,100,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,CF,Cash flow statement,ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges,현금및현금성자산의 증감,-,Term 24,322073920308,Term 23,250085194284,Term 22,-73717607362,101,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,연결재무제표 [member],Term 24,5548926465800,Term 23,5468835988249,Term 22,5497832811356,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|비지배지분 [구성요소],Term 24,115475406911,Term 23,129553438347,Term 22,109822657026,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,5433451058889,Term 23,5339282549902,Term 22,5388010154330,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-260224352418,Term 23,-305870275565,Term 22,-217431509911,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-96665276609,Term 23,-83209267310,Term 22,-64495577286,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,5604425480133,Term 23,5542446884994,Term 22,5484022033744,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,dart_EquityAtBeginningOfPeriod,기초자본,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,3,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,58750966950,Term 23,67128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|비지배지분 [구성요소],Term 24,1004431844,Term 23,30000000000,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,연결재무제표 [member],Term 24,59755398794,Term 23,97128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,58750966950,Term 23,67128988950,Term 22,201177340950,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_DividendsPaid,현금배당,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,4,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,연결재무제표 [member],Term 24,5685920091079,Term 23,5548926465800,Term 22,5468835988249,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|비지배지분 [구성요소],Term 24,119655719140,Term 23,115475406911,Term 22,129553438347,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,5566264371939,Term 23,5433451058889,Term 22,5339282549902,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,88589470000,Term 23,88589470000,Term 22,88589470000,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,5695579977322,Term 23,5604425480133,Term 22,5542446884994,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-17528901762,Term 23,-96665276609,Term 22,-83209267310,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-297701911404,Term 23,-260224352418,Term 22,-305870275565,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_Equity,자본 총계,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,97325737783,Term 23,97325737783,Term 22,97325737783,5,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-37477558986,Term 23,45645923147,Term 22,-88438765654,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|비지배지분 [구성요소],Term 24,-16659113386,Term 23,-4491595670,Term 22,-4735358117,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,연결재무제표 [member],Term 24,-54136672372,Term 23,41154327477,Term 22,-93174123771,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,-37477558986,Term 23,45645923147,Term 22,-88438765654,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity,비지배지분의 변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,6,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,79557036584,Term 23,-14905028256,Term 22,-18538307951,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|비지배지분 [구성요소],Term 24,8106453665,Term 23,436339317,Term 22,1241417342,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,연결재무제표 [member],Term 24,87663490249,Term 23,-14468688939,Term 22,-17296890609,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,79557036584,Term 23,-14905028256,Term 22,-18538307951,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation,해외사업환산손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,7,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-420661737,Term 23,-45654236,Term 22,-226822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|비지배지분 [구성요소],Term 24,0,Term 23,883146,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,연결재무제표 [member],Term 24,-420661737,Term 23,-44771090,Term 22,-226822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,7948316,Term 22,197100000,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments,기타포괄손익-공정가치 측정 금융자산 평가손익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,-420661737,Term 23,-53602552,Term 22,-197326822,8,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),연결재무제표 [member],Term 24,-40244862206,Term 23,-14448242436,Term 22,24289767415,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|비지배지분 [구성요소],Term 24,-1015567917,Term 23,-792398853,Term 22,1457101023,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,-39229294289,Term 23,-13655843583,Term 22,22832666392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,-39229294289,Term 23,-13655843583,Term 22,22832666392,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans,확정급여제도의 재측정손익(세후기타포괄손익),자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,9,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,연결재무제표 [member],Term 24,203887730139,Term 23,163524219980,Term 22,258340046881,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|비지배지분 [구성요소],Term 24,14752971711,Term 23,20768740624,Term 22,21767621073,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,189134758428,Term 23,142755479356,Term 22,236572425808,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ProfitLoss,당기순이익,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,10,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,연결재무제표 [member],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|비지배지분 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타포괄손익누적액 [구성요소],Term 24,0,Term 23,1502621509,Term 22,21944749,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|이익잉여금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|자본금 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
20250317000790,11011,2024,00356370,SCE,Statement of changes in equity,ifrs-full_ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodThatWillBeReclassifiedToProfitOrLossNetOfTax,지분법자본변동,자본 [구성요소]|지배기업의 소유주에게 귀속되는 지분 [구성요소]|기타자본구성요소 [구성요소],Term 24,0,Term 23,0,Term 22,0,11,KRW,,opendart_fnlttSinglAcntAll,CFS,11011,BS,051900,LG생활건강
